RNAi as an experimental and therapeutic tool to study and regulate physiological and disease processes

Annual Review of Physiology

Volumn 67, Issue , 2005, Pages 147-173

  Dillon, Christopher P ^a   Sandy, Peter ^a   Nencioni, Alessio ^a   Kissler, Stephan ^a   Rubinson, Douglas A ^a   Van Parijs, Luk ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

MicroRNA; shRNA; siRNA; Therapy; Vector

Indexed keywords

DOUBLE STRANDED RNA; ECDYSONE; LIPOSOME; MICRORNA; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TETRACYCLINE; VIRUS VECTOR;

AUTOIMMUNE DISEASE; CAENORHABDITIS ELEGANS; CANCER; DROSOPHILA MELANOGASTER; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; HUMAN; MAMMAL CELL; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA INTERFERENCE; TRANSCRIPTION REGULATION; TRANSGENIC ANIMAL; VIRAL GENE DELIVERY SYSTEM; VIRUS INFECTION;

ANIMALS; BIOMEDICAL RESEARCH; HUMANS; PHYSIOLOGY; RNA INTERFERENCE; THERAPEUTICS;

EID: 15544377122     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.67.040403.130716     Document Type: Review

References (219)

1. Sharp PA. 1999. RNAi and double-strand RNA. Genes Dev. 13:139-41
2. Baulcombe DC. 1999. Fast forward genetics based on virus-induced gene silencing. Curr. Opin. Plant Biol. 2:109-13
3. Caplen NJ, Fleenor J, Fire A, Morgan RA. 2000. dsRNA-mediated gene silencing in cultured Drosophila cells: a tissue culture model for the analysis of RNA interference. Gene. 252:95-105
4. Ui-Tei K, Zenno S, Miyata Y, Saigo K. 2000. Sensitive assay of RNA interference in Drosophila and Chinese hamster cultured cells using firefly luciferase gene as target. FEBS. Lett. 479:79-82
5. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-64
6. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-98
7. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806-11
8. Hutvagner G, Zamore PD. 2002. RNAi: nature abhors a double-strand. Curr. Opin. Genet. Dev. 12:225-32
9. Lee RC, Feinbaum RL, Ambros V. 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843-54
10. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. 2001. Identification of novel genes coding for small expressed RNAs. Science 294:853-58
11. Lau NC, Lim LP, Weinstein EG, Bartel DP. 2001. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294:858-62
12. Lee RC, Ambros V. 2001. An extensive class of small RNAs in Caenorhabditis elegans. Science 294:862-64
13. Lim LP, Glasner ME, Yekta S, Burge CB, Bartel DP. 2003. Vertebrate microRNA genes. Science 299:1540
14. Chen CZ, Li L, Lodish HF, Bartel DP. 2004. MicroRNAs modulate hematopoietic lineage differentiation. Science 303:83-86
15. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, et al. 2002. Frequent deletions and down-regulation of microRNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 99:15524-29
16. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, et al. 2004. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA 101:2999-3004
17. Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-97
18. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. 2002. Identification of tissue-specific micro RNAs from mouse. Curr. Biol. 12:735-39
19. Lee Y, Jeon K, Lee JT, Kim S, Kim VN. 2002. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 21:4663-70
20. Lee Y, Ahn C, Han J, Choi H, Kim J, et al. 2003. The nuclear RNase III Drosha initiates microRNA processing. Nature 425:415-19
21. Bernstein E, Caudy AA, Hammond SM, Hannon GJ. 2001. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409:363-66
22. Hutvagner G, Zamore PD. 2002. A microRNA in a multiple-turnover RNAi enzyme complex. Science 297:2056-60
23. Williams RW, Rubin GM. 2002. ARGONAUTE1 is required for efficient RNA interference in Drosophila embryos. Proc. Natl. Acad. Sci. USA 99:6889-94
24. Hammond SM, Boettcher S, Caudy AA, Kobayashi R, Hannon GJ. 2001. Argonaute2, a link between genetic and biochemical analyses of RNAi. Science 293:1146-50
25. Sasaki T, Shiohama A, Minoshima S, Shimizu N. 2003. Identification of eight members of the Argonaute family in the human genome small star, filled. Genomics 82:323-30
26. Tabara H, Sarkissian M, Kelly WG, Fleenor J, Grishok A, et al. 1999. The rde-1 gene, RNA interference, and transposon silencing in C. elegans. Cell 99:123-32
27. Morel JB, Godon C, Mourrain P, Beclin C, Boulet S, et al. 2002. Fertile hypomorphic ARGONAUTE (ago1) mutants impaired in post-transcriptional gene silencing and virus resistance. Plant Cell 14:629-39
28. Mourelatos Z, Dostie J, Paushkin S, Sharma A, Charroux B, et al. 2002. miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev. 16:720-28
29. Martinez J, Patkaniowska A, Urlaub H, Luhrmann R, Tuschl T. 2002. Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 110:563-74
30. Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, et al. 2003. Dicer is essential for mouse development. Nat. Genet. 35:215-17
31. Wienholds E, Koudijs MJ, van Eeden FJ, Cuppen E, Plasterk RH. 2003. The microRNA-producing enzyme Dicer1 is essential for zebrafish development. Nat. Genet. 35:217-18
32. Grishok A, Pasquinelli AE, Conte D, Li N, Parrish S, et al. 2001. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 106:23-34
33. Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T, Zamore PD. 2001. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293:834-38
34. Ketting RF, Fischer SE, Bernstein E, Sijen T, Hannon GJ, Plasterk RH. 2001. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev. 15:2654-59
35. Bartel DP, Chen CZ. 2004. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat. Rev. Genet. 5:396-400
36. Doench JG, Petersen CP, Sharp PA. 2003. siRNAs can function as miRNAs. Genes Dev. 17:438-42
37. Dykxhoorn DM, Novina CD, Sharp PA. 2003. Killing the messenger: short RNAs that silence gene expression. Nat. Rev. Mol. Cell. Biol. 4:457-67
38. Brummelkamp TR, Bernards R, Agami R. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550-53
39. Sui G, Soohoo C, Affar el B, Gay F, Shi Y, Forrester WC. 2002. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA 99:5515-20
40. Paddison PJ, Caudy AA, Hannon GJ. 2002. Stable suppression of gene expression by RNAi in mammalian cells. Proc. Natl. Acad. Sci. USA 99:1443-48
41. Shinagawa T, Ishii S. 2003. Generation of Ski-knockdown mice by expressing along double-strand RNA from an RNA polymerase II promoter. Genes Dev. 17:1340-45
42. Tuschl T, Zamore PD, Lehmann R, Bartel DP, Sharp PA. 1999. Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev. 13:3191-97
43. Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD. 2003. Asymmetry in the assembly of the RNAi enzyme complex. Cell 115:199-208
44. Khvorova A, Reynolds A, Jayasena SD. 2003. Functional siRNAs and miRNAs exhibit strand bias. Cell 115:209-16
45. Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A. 2004. Rational siRNA design for RNA interference. Nat. Biotechnol. 22:326-30
46. Sijen T, Fleenor J, Simmer F, Thijssen KL, Parrish S, et al. 2001. On the role of RNA amplification in dsRNA-triggered gene silencing. Cell 107:465-76
47. Smardon A, Spoerke JM, Stacey SC, Klein ME, Mackin N, Maine EM. 2000. EGO-1 is related to RNA-directed RNA polymerase and functions in germ-line development and RNA interference in C. elegans. Curr. Biol 10:169-78
48. Song E, Lee SK, Wang J, Ince N, Ouyang N, et al. 2003. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 9:347-51
49. Song E, Lee SK, Dykxhoorn DM, Novina C, Zhang D, et al. 2003. Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages. J. Virol. 77:7174-81
50. Paule MR, White RJ. 2000. Survey and summary: transcription by RNA polymerases I and III. Nucleic Acids Res. 28:1283-98
51. Boden D, Pusch O, Lee F, Tucker L, Shank PR, Ramratnam B. 2003. Promoter choice affects the potency of HIV-1 specific RNA interference. Nucleic Acids Res. 31:5033-38
52. Kawasaki H, Taira K. 2003. Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells. Nucleic Acids Res. 31:700-7
53. Zhang L, Yang N, Mohamed-Hadley A, Rubin SC, Coukos G. 2003. Vector-based RNAi, a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer. Biochem Biophys. Res. Commun. 303:1169-78
54. Xia XG, Zhou H, Ding H, Affar el B, Shi Y, Xu Z. 2003. An enhanced U6 promoter for synthesis of short hairpin RNA. Nucleic Acids Res. 31:e100
55. Xia H, Mao Q, Paulson HL, Davidson BL. 2002. siRNA-mediated gene silencing in vitro and in vivo. Nat. Biotechnol. 20:1006-10
56. Zeng Y, Wagner EJ, Cullen BR. 2002. Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol. Cell. 9:1327-33
57. McManus MT, Haines BB, Dillon CP, Whitehurst CE, van Parijs L, et al. 2002. Small interfering RNA-mediated gene silencing in T lymphocytes. J. Immunol. 169:5754-60
58. Brummelkamp TR, Bernards R, Agami R. 2002. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2:243-47
59. Pusch O, Boden D, Silbermann R, Lee F, Tucker L, Ramratnam B. 2003. Nucleotide sequence homology requirements of HIV-1-specific short hairpin RNA. Nucleic Acids Res. 31:6444-49
60. Persengiev SP, Zhu X, Green MR. 2004. Nonspecific, concentration- dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10:12-18
61. Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, et al. 2003. Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 21:635-37
62. Saxena S, Jonsson ZO, Dutta A. 2003. Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells. J. Biol. Chem. 278:44312-19
63. a. Mittal V. 2004. Improving the efficiency of RNA interference in mammals. Nat. Rev. Genet. 5:355-65
64. Zamore PD. 2001. RNA interference: listening to the sound of silence. Nat. Struct. Biol. 8:746-50
65. Bridge AJ, Pebernard S, Ducraux A, Nicoulaz AL, Iggo R. 2003. Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34:263-64
66. Kim DH, Longo M, Han Y, Lundberg P, Cantin E, Rossi JJ. 2004. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat. Biotechnol. 22:321-25
67. Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BR. 2003. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5:834-39
68. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413:732-38
69. Kariko K, Bhuyan P, Capodici J, Weissman D. 2004. Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through Toll-like receptor 3. J. Immunol. 172:6545-49
70. McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ, Kay MA. 2002. RNA interference in adult mice. Nature 418:38-39
71. Lewis DL, Hagstrom JE, Loomis AG, Wolff JA, Herweijer H. 2002. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat. Genet. 32:107-8
72. Sorensen DR, Leirdal M, Sioud M. 2003. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J. Mol. Biol. 327:761-66
73. Baker-Herman TL, Fuller DD, Bavis RW, Zabka AG, Golder FJ, et al. 2004. BDNF is necessary and sufficient for spinal respiratory plasticity following intermittent hypoxia. Nat. Neurosci. 7:48-55
74. Kishida T, Asada H, Gojo S, Ohashi S, Shin-Ya M, et al. 2004. Sequence-specific gene silencing in murine muscle induced by electroporation-mediated transfer of short interfering RNA. J. Gene Med. 6:105-10
75. Konishi Y, Stegmuller J, Matsuda T, Bonni S, Bonni A. 2004. Cdh1-APC controls axonal growth and patterning in the mammalian brain. Science 303:1026-30
76. Kong XC, Barzaghi P, Ruegg MA. 2004. Inhibition of synapse assembly in mammalian muscle in vivo by RNA interference. EMBO Rep. 5:183-88
77. Matsuda T, Cepko CL. 2004. Electroporation and RNA interference in the rodent retina in vivo and in vitro. Proc. Natl. Acad. Sci. USA 101:16-22
78. Braasch DA, Jensen S, Liu Y, Kaur K, Arar K, et al. 2003. RNA interference in mammalian cells by chemically-modified RNA. Biochemistry 42:7967-75
79. Braasch DA, Paroo Z, Constantinescu A, Ren G, Oz OK, et al. 2004. Biodistribution of phosphodiester and phosphorothioate siRNA. Bioorg. Med. Chem. Lett. 14:1139-43
80. Czauderna F, Fechtner M, Dames S, Aygun H, Klippel A, et al. 2003. Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res. 31:2705-16
81. Chiu YL, Rana TM. 2003. siRNA function in RNAi: a chemical modification analysis. RNA 9:1034-48
82. Zhang Y, Boado RJ, Pardridge WM. 2003. In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats. J. Gene Med. 5:1039-45
83. Muratovska A, Eccles MR. 2004. Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells. FEBS Lett. 558:63-68
84. Lois C, Refaeli Y, Qin XF, Van Parijs L. 2001. Retroviruses as tools to study the immune system. Curr. Opin. Immunol. 13:496-504
85. Abbas-Terki T, Blanco-Bose W, Deglon N, Pralong W, Aebischer P. 2002. Lentiviral-mediated RNA interference. Hum. Gene Ther. 13:2197-201
86. Dirac AM, Bernards R. 2003. Reversal of senescence in mouse fibroblasts through lentiviral suppression of p53. J. Biol. Chem. 278:11731-34
87. Hemann MT, Fridman JS, Zilfou JT, Hernando E, Paddison PJ, et al. 2003. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat. Genet. 33:396-400
88. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, et al. 2003. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33:401-6
89. Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, et al. 2003. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9:493-501
90. Tiscornia G, Singer O, Ikawa M, Verma IM. 2003. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc. Natl. Acad. Sci. USA 100:1844-48
91. Qin XF, An DS, Chen IS, Baltimore D. 2003. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl. Acad. Sci. USA 100:183-88
92. Hommel JD, Sears RM, Georgescu D, Simmons DL, DiLeone RJ. 2003. Local gene knockdown in the brain using viral-mediated RNA interference. Nat. Med. 9:1539-44
93. Arts GJ, Langemeijer E, Tissingh R, Ma L, Pavliska H, et al. 2003. Adenoviral vectors expressing siRNAs for discovery and validation of gene function. Genome Res. 13:2325-32
94. Shen C, Buck AK, Liu X, Winkler M, Reske SN. 2003. Gene silencing by adenovirus-delivered siRNA. FEBS Lett. 539:111-14
95. Zhao LJ, Jian H, Zhu H. 2003. Specific gene inhibition by adenovirus-mediated expression of small interfering RNA. Gene 316:137-41
96. Hildinger M, Auricchio A. 2004. Advances in AAV-mediated gene transfer for the treatment of inherited disorders. Eur. J. Hum. Genet. 12:263-71
97. Kay MA, Nakai H. 2003. Looking into the safety of AAV vectors. Nature 424:251
98. Thomas CE, Ehrhardt A, Kay MA. 2003. Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet. 4:346-58
99. Boden D, Pusch O, Lee F, Tucker L, Ramratnam B. 2004. Efficient gene transfer of HIV-1-specific short hairpin RNA into human lymphocytic cells using recombinant adeno-associated virus vectors. Mol. Ther. 9:396-402
100. Xia H, Mao Q, Eliason SL, Harper SQ, Martins IH, et al. 2004. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat. Med. 10:816-20
101. Hasuwa H, Kaseda K, Einarsdottir T, Okabe M. 2002. Small interfering RNA and gene silencing in transgenic mice and rats. FEBS Lett. 532:227-30
102. Stein P, Svoboda P, Schultz RM. 2003. Transgenic RNAi in mouse oocytes: a simple and fast approach to study gene function. Dev. Biol. 256:187-93
103. Fedoriw AM, Stein P, Svoboda P, Schultz RM, Bartolomei MS. 2004. Transgenic RNAi reveals essential function for CTCF in H19 gene imprinting. Science 303:238-40
104. Carmell MA, Zhang L, Conklin DS, Hannon GJ, Rosenquist TA. 2003. Germline transmission of RNAi in mice. Nat. Struct. Biol. 10:91-92
105. Kunath T, Gish G, Lickert H, Jones N, Pawson T, Rossant J. 2003. Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype. Nat. Biotechnol. 21:559-61
106. Gonczy P, Echeverri C, Oegema K, Coulson A, Jones SJ, et al. 2000. Functional genomic analysis of cell division in C. elegans using RNAi of genes on chromosome III. Nature 408:331-36
107. Fraser AG, Kamath RS, Zipperlen P, Martinez-Campos M, Sohrmann M, Ahringer J. 2000. Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature 408:325-30
108. Timmons L, Court DL, Fire A. 2001. Ingestion of bacterially expressed dsRNAs can produce specific and potent genetic interference in Caenorhabditis elegans. Gene 263:103-12
109. Timmons L, Fire A. 1998. Specific interference by ingested dsRNA. Nature 395:854
110. Kamath RS, Fraser AG, Dong Y, Poulin G, Durbin R, et al. 2003. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 421:231-37
111. Simmer F, Moorman C, Van Der Linden AM, Kuijk E, Van Den Berghe PV, et al. 2003. Genome-wide RNAi of C. elegans using the hypersensitive rrf-3 strain reveals novel gene functions. PLoS Biol. 1:E12
112. Lee SS, Lee RY, Fraser AG, Kamath RS, Ahringer J, Ruvkun G. 2003. A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity. Nat. Genet. 33:40-48
113. Ashrafi K, Chang FY, Watts JL, Fraser AG, Kamath RS, et al. 2003. Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature 421:268-72
114. Pothof J, van Haaften G, Thijssen K, Kamath RS, Fraser AG, et al. 2003. Identification of genes that protect the C. elegans genome against mutations by genome-wide RNAi. Genes Dev. 17:443-48
115. Piano F, Schetter AJ, Mangone M, Stein L, Kemphues KJ. 2000. RNAi analysis of genes expressed in the ovary of Caenorhabditis elegans. Curr. Biol. 10:1619-22
116. Kennedy S, Wang D, Ruvkun G. 2004. A conserved siRNA-degrading RNase negatively regulates RNA interference in C. elegans. Nature 427:645-49
117. Muda M, Worby CA, Simonson-Leff N, Clemens JC, Dixon JE. 2002. Use of double-stranded RNA-mediated interference to determine the substrates of protein tyrosine kinases and phosphatases. Biochem. J. 366:73-77
118. Clemens JC, Worby CA, Simonson-Leff N, Muda M, Maehama T, et al. 2000. Use of double-stranded RNA interference in Drosophila cell lines to dissect signal transduction pathways. Proc. Natl. Acad. Sci. USA 97:6499-503
119. Lum L, Yao S, Mozer B, Rovescalli A, Von Kessler D, et al. 2003. Identification of Hedgehog pathway components by RNAi in Drosophila cultured cells. Science 299:2039-45
120. Kiger A, Baum B, Jones S, Jones M, Coulson A, et al. 2003. A functional genomic analysis of cell morphology using RNA interference. J. Biol. 2:27
121. Kim YO, Park SJ, Balaban RS, Nirenberg M, Kim Y. 2004. A functional genomic screen for cardiogenic genes using RNA interference in developing Drosophila embryos. Proc. Natl. Acad. Sci. USA 101:159-64
122. Somma MP, Fasulo B, Cenci G, Cundari E, Gatti M. 2002. Molecular dissection of cytokinesis by RNA interference in Drosophila cultured cells. Mol. Biol. Cell. 13:2448-60
123. Ramet M, Manfruelli P, Pearson A, Mathey-Prevot B, Ezekowitz RA. 2002. Functional genomic analysis of phagocytosis and identification of a Drosophila receptor for E. coli. Nature 416:644-48
124. Foley E, O'Farrell PH. 2004. Functional dissection of an innate immune response by a genome-wide RNAi screen. PLoS Biol. 2:E203
125. Boutros M, Kiger AA, Armknecht S, Kerr K, Hild M, et al. 2004. Genome-wide RNAi analysis of growth and viability in Drosophila cells. Science 303:832-35
126. Aza-Blanc P, Cooper CL, Wagner K, Batalov S, Deveraux QL, Cooke MP. 2003. Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening. Mol. Cell. 12:627-37
127. Brummelkamp TR, Nijman SM, Dirac AM, Bernards R. 2003. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 424:797-801
128. Berns K, Hijmans EM, Mullenders J, Brummelkamp TR, Velds A, et al. 2004. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428:431-37
129. Paddison PJ, Silva JM, Conklin DS, Schlabach M, Li M, et al. 2004. A resource for large-scale RNA-interference-based screens in mammals. Nature 428:427-31
130. Zheng L, Liu J, Batalov S, Zhou D, Orth A, et al. 2004. An approach to genomewide screens of expressed small interfering RNAs in mammalian cells. Proc. Natl. Acad. Sci. USA 101:135-40
131. Kumar R, Conklin DS, Mittal V. 2003. High-throughput selection of effective RNAi probes for gene silencing. Genome Res. 13:2333-40
132. Mousses S, Caplen NJ, Cornelison R, Weaver D, Basik M, et al. 2003. RNAi microarray analysis in cultured mammalian cells. Genome Res. 13:2341-47
133. Lieberman J, Song E, Lee SK, Shankar P. 2003. Interfering with disease: opportunities and roadblocks to harnessing RNA interference. Trends Mol. Med. 9:397-403
134. Wall NR, Shi Y. 2003. Small RNA: can RNA interference be exploited for therapy? Lancet 362:1401-3
135. Kitabwalla M, Ruprecht RM. 2002. RNA interference - a new weapon against HIV and beyond. N. Engl. J. Med. 347:1364-67
136. Ding H, Schwarz DS, Keene A, Affar el B, Fenton L, et al. 2003. Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis. Aging Cell 2:209-17
137. Wohlbold L, van der Kuip H, Miething C, Vomlocher HP, Knabbe C, et al. 2003. Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571). Blood 102:2236-39
138. Wilda M, Fuchs U, Wossmann W, Borkhardt A. 2002. Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene 21:5716-24
139. Yin JQ, Gao J, Shao R, Tian WN, Wang J, Wan Y. 2003. siRNA agents inhibit oncogene expression and attenuate human tumor cell growth. J. Exp. Ther. Oncol. 3:194-204
140. Filleur S, Courtin A, Ait-Si-Ali S, Guglielmi J, Merle C, et al. 2003. SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth. Cancer Res. 63:3919-22
141. Duxbury MS, Ito H, Benoit E, Zinner MJ, Ashley SW, Whang EE. 2003. RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity. Biochem. Biophys. Res. Commun. 311:786-92
142. Lima RT, Martins LM, Guimaraes JE, Sambade C, Vasconcelos MH. 2004. Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells. Cancer Gene Ther. 11:309-16
143. Nieth C, Priebsch A, Stege A, Lage H. 2003. Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi). FEBS Lett. 545:144-50
144. Butz K, Ristriani T, Hengstermann A, Denk C, Scheffner M, Hoppe-Seyler F. 2003. siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene 22:5938-45
145. Hall AH, Alexander KA. 2003. RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells. J. Virol. 77:6066-69
146. Ge Q, McManus MT, Nguyen T, Shen CH, Sharp PA, et al. 2003. RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc. Natl. Acad. Sci. USA 100:2718-23
147. Giladi H, Ketzinel-Gilad M, Rivkin L, Felig Y, Nussbaum O, Galun E. 2003. Small interfering RNA inhibits hepatitis B virus replication in mice. Mol. Ther. 8:769-76
148. Yokota T, Sakamoto N, Enomoto N, Tanabe Y, Miyagishi M, et al. 2003. Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. EMBO Rep. 4:602-8
149. Kronke J, Kittler R, Buchholz F, Windisch MP, Pietschmann T, et al. 2004. Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs. J. Virol. 78:3436-46
150. Zhang Y, Li T, Fu L, Yu C, Li Y, et al. 2004. Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference. FEBS Lett. 560:141-46
151. Ge Q, Filip L, Bai A, Nguyen T, Eisen HN, Chen J. 2004. Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc. Natl. Acad. Sci. USA 101:8676-81
152. Das AT, Brummelkamp TR, Westerhout EM, Vink M, Madiredjo M, et al. 2004. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J. Virol. 78:2601-5
153. Boden D, Pusch O, Lee F, Tucker L, Ramratnam B. 2003. Human immunodeficiency virus type 1 escape from RNA interference. J. Virol. 77:11531-35
154. Wang X, Huong SM, Chiu ML, Raab-Traub N, Huang ES. 2003. Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus. Nature 424:456-61
155. Zender L, Hutker S, Liedtke C, Tillmann HL, Zender S, et al. 2003. Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc. Natl. Acad. Sci. USA 100:7797-802
156. Kao SC, Krichevsky AM, Kosik KS, Tsai LH. 2004. BACE1 suppression by RNA interference in primary cortical neurons. J. Biol. Chem. 279:1942-49
157. Tilly G, Chapuis J, Vilette D, Laude H, Vilotte JL. 2003. Efficient and specific down-regulation of prion protein expression by RNAi. Biochem. Biophys. Res. Commun. 305:548-51
158. Sioud M, Sorensen DR. 2003. Cationic liposome-mediated delivery of siRNAs in adult mice. Biochem. Biophys. Res. Commun. 312:1220-25
159. Bologna JC, Dorn G, Natt F, Weiler J. 2003. Linear polyethylenimine as a tool for comparative studies of antisense and short double-stranded RNA oligonucleotides. Nucleosides Nucleotides Nucleic Acids 22:1729-31
160. Chang FH, Lee CH, Chen MT, Kuo CC, Chiang YL, et al. 2004. Surfection: a new platform for transfected cell arrays. Nucleic Acids Res. 32:e33
161. Hill JA, Ichim TE, Kusznieruk KP, Li M, Huang X, et al. 2003. Immune modulation by silencing IL-12 production in dendritic cells using small interfering RNA. J. Immunol. 171:691-96
162. Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, et al. 2003. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348:255-56
163. Wang J, Tekle E, Oubrahim H, Mieyal JJ, Stadtman ER, Chock PB. 2003. Stable and controllable RNA interference: investigating the physiological function of glutathionylated actin. Proc. Natl. Acad. Sci. USA 100:5103-6
164. Chen Y, Stamatoyannopoulos G, Song CZ. 2003. Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res. 63:4801-4
165. Czauderna F, Santel A, Hinz M, Fechtner M, Durieux B, et al. 2003. Inducible shRNA expression for application in a prostate cancer mouse model. Nucleic Acids Res. 31:e127
166. Wiznerowicz M, Trono D. 2003. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J. Virol. 77:8957-61
167. Matsukura S, Jones PA, Takai D. 2003. Establishment of conditional vectors for hairpin siRNA knockdowns. Nucleic Acids Res. 31:e77
168. van de Watering M, Oving I, Muncan V, Pon Fong MT, Brantjes H, et al. 2003. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep. 4:609-15
169. Tiscornia G, Tergaonkar V, Galimi F, Verma IM. 2004. CRE recombinase-inducible RNA interference mediated by lentiviral vectors. Proc. Natl. Acad. Sci. USA 101:7347-51
170. Ventura A, Meissner A, Dillon CP, McManus M, Sharp PA, et al. 2004. Crelox-regulated conditional RNA interference from transgenes. Proc. Natl. Acad. Sci. USA 101:10380-85
171. Kasim V, Miyagishi M, Taira K. 2003. Control of siRNA expression utilizing Cre-loxP recombination system. Nucleic Acids Res. Suppl. 3:255-56
172. Fritsch L, Martinez LA, Sekhri R, Naguibneva I, Gerard M, et al. 2004. Conditional gene knock-down by CRE-dependent short interfering RNAs. EMBO Rep. 5:178-82
173. Gupta S, Schoer RA, Egan JE, Hannon GJ, Mittal V. 2004. Inducible, reversible, and stable RNA interference in mammalian cells. Proc. Natl. Acad. Sci. USA 101:1927-32
174. Kamath RS, Ahringer J. 2003. Genome-wide RNAi screening in Caenorhabditis elegans. Methods 30:313-21
175. Piano F, Schetter AJ, Morton DG, Gunsalus KC, Reinke V, et al. 2002. Gene clustering based on RNAi phenotypes of ovary-enriched genes in C. elegans. Curr. Biol. 12:1959-64
176. Yamamoto T, Omoto S, Mizuguchi M, Mizukami H, Okuyama H, et al. 2002. Double-stranded nef RNA interferes with human immunodeficiency virus type 1 replication. Microbiol. Immunol. 46:809-17
177. Park WS, Miyano-Kurosaki N, Hayafune M, Nakajima E, Matsuzaki T, et al. 2002. Prevention of HIV-1 infection in human peripheral blood mononuclear cells by specific RNA interference. Nucleic Acids Res. 30:4830-35
178. Capodici J, Kariko K, Weissman D. 2002. Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. J. Immunol 169:5196-201
179. Nishitsuji H, Ikeda T, Miyoshi H, Ohashi T, Kannagi M, Masuda T. 2004. Expression of small hairpin RNA by lentivirus-based vector confers efficient and stable gene-suppression of HIV-1 on human cells including primary non-dividing cells. Microb. Infect. 6:76-85
180. Lee NS, Dohjima T, Bauer G, Li H, Li MJ, et al. 2002. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 20:500-5
181. Coburn GA, Cullen BR. 2002. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J. Virol. 76:9225-31
182. Jacque JM, Triques K, Stevenson M. 2002. Modulation of HIV-1 replication by RNA interference. Nature 418:435-38
183. Park WS, Miyano-Kurosaki N, Nakajima E, Takaku H. 2001. Specific inhibition of HIV-1 gene expression by double-stranded RNA. Nucleic Acids Res. Suppl. 1:219-20
184. Park WS, Hayafune M, Miyano-Kurosaki N, Takaku H. 2003. Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells. Gene Ther. 10:2046-50
185. Novina CD, Murray MF, Dykxhoorn DM, Beresford PJ, Riess J, et al. 2002. siRNA-directed inhibition of HIV-1 infection. Nat. Med. 8:681-86
186. Butticaz C, Ciuffi A, Munoz M, Thomas J, Bridge A, et al. 2003. Protection from HIV-1 infection of primary CD4 T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression. Antiviral. Ther. 8:373-77
187. Martinez MA, Gutierrez A, Armand-Ugon M, Blanco J, Parera M, et al. 2002. Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication. AIDS 16:2385-90
188. Anderson J, Banerjea A, Planelles V, Akkina R. 2003. Potent suppression of HIV type 1 infection by a short hairpin anti-CXCR4 siRNA. AIDS Res. Hum. Retroviruses 19:699-706
189. Chiu YL, Cao H, Jacque JM, Stevenson M, Rana TM. 2004. Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1). J. Virol. 78:2517-29
190. Anderson J, Banerjea A, Akkina R. 2003. Bispecific short hairpin siRNA constructs targeted to CD4, CXCR4, and CCR5 confer HIV-1 resistance. Oligonucleotides 13:303-12
191. Shlomai A, Shaul Y. 2003. Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology 37:764-70
192. McCaffrey AP, Nakai H, Pandey K, Huang Z, Salazar FH, et al. 2003. Inhibition of hepatitis B virus in mice by RNA interference. Nat. Biotechnol. 21:639-44
193. Ying C, De Clercq E, Neyts J. 2003. Selective inhibition of hepatitis B virus replication by RNA interference. Biochem. Biophys. Res. Commun. 309:482-84
194. Shlomai A, Shaul Y, Kapadia SB, Brideau-Andersen A, Chisari FV, et al. 2003. Inhibition of hepatitis B virus expression and replication by RNA
195. Seo MY, Abrignani S, Houghton M, Han JH. 2003. Small interfering RNA-mediated inhibition of hepatitis C virus replication in the human hepatoma cell line Huh-7. J. Virol. 77:810-12
196. Sen A, Steele R, Ghosh AK, Basu A, Ray R, Ray RB. 2003. Inhibition of hepatitis C virus protein expression by RNA interference. Virus Res. 96:27-35
197. Chang J, Taylor JM. 2003. Susceptibility of human hepatitis delta virus RNAs to small interfering RNA action. J. Virol. 77:9728-31
198. Wiebusch L, Truss M, Hagemeier C. 2004. Inhibition of human cytomegalovirus replication by small interfering RNAs. J. Gen. Virol. 85:179-84
199. Phipps KM, Martinez A, Lu J, Heinz BA, Zhao G. 2004. Small interfering RNA molecules as potential anti-human rhinovirus agents: in vitro potency, specificity, and mechanism. Antiviral. Res. 61:49-55
200. Jia Q, Sun R. 2003. Inhibition of gamma-herpesvirus replication by RNA interference. J. Virol. 77:3301-6
201. Maxwell MM, Pasinelli P, Kazantsev AG, Brown RH Jr. 2004. RNA interference-mediated silencing of mutant superoxide dismutase rescues cyclosporin A-induced death in cultured neuroblastoma cells. Proc. Natl. Acad. Sci. USA 101:3178-83
202. Abdelgany A, Wood M, Beeson D. 2003. Allele-specific silencing of a pathogenic mutant acetylcholine receptor subunit by RNA interference. Hum. Mol. Genet. 12:2637-44
203. Grzmil M, Thelen P, Hemmerlein B, Schweyer S, Voigt S, et al. 2003. Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells. Am. J. Pathol. 163:543-52
204. Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. 2004. EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma. Oncogene 23:1448-56
205. Sanceau J, Truchet S, Bauvois B. 2003. Matrix metalloproteinase-9 silencing by RNA interference triggers the migratory-adhesive switch in Ewing's sarcoma cells. J. Biol. Chem. 278:36537-46
206. Heidenreich O, Krauter J, Riehle H, Hadwiger P, John M, et al. 2003. AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8;21)-positive leukemic cells. Blood 101:3157-63
207. Hingorani SR, Jacobetz MA, Robertson GP, Herlyn M, Tuveson DA. 2003. Suppression of BRAF(V599E) in human melanoma abrogates transformation. Cancer Res. 63:5198-202
208. Harvey AJ, Crompton MR. 2003. Use of RNA interference to validate Brk as a novel therapeutic target in breast cancer: Brk promotes breast carcinoma cell proliferation. Oncogene 22:5006-10
209. Li XP, Li G, Peng Y, Kung HF, Lin MC. 2004. Suppression of Epstein-Barr virus-encoded latent membrane protein-1 by RNA interference inhibits the metastatic potential of nasopharyngeal carcinoma cells. Biochem. Biophys. Res. Commun. 315:212-18
210. Nagy P, Arndt-Jovin DJ, Jovin TM. 2003. Small interfering RNAs suppress the expression of endogenous and GFP-fused epidermal growth factor receptor (erbB1) and induce apoptosis in erbB1-overexpressing cells. Exp. Cell Res. 285:39-49
211. Zhang M, Zhang X, Bai CX, Chen J, Wei MQ. 2004. Inhibition of epidermal growth factor receptor expression by RNA interference in A549 cells. Acta Pharmacol. Sin. 25:61-67
212. De Schrijver E, Brusselmans K, Heyns W, Verhoeven G, Swinnen JV. 2003. RNA interference-mediated silencing of the fatty acid synthase gene attenuates growth and induces morphological changes and apoptosis of LNCaP prostate cancer cells. Cancer Res. 63:3799-804
213. Crnkovic-Mertens I, Hoppe-Seyler F, Butz K. 2003. Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene. Oncogene 22:8330-36
214. Futami T, Miyagishi M, Seki M, Taira K. 2002. Induction of apoptosis in HeLa cells with siRNA expression vector targeted against bcl-2. Nucleic Acids Res. Suppl. 2:251-52
215. Spankuch-Schmitt B, Bereiter-Hahn J, Kaufmann M, Strebhardt K. 2002. Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells. J. Natl. Cancer Inst. 94:1863-77
216. Kosciolek BA, Kalantidis K, Tabler M, Rowley PT. 2003. Inhibition of telomerase activity in human cancer cells by RNA interference. Mol. Cancer Ther. 2:209-16
217. Zhang L, Fogg DK, Waisman DM. 2004. RNA interference-mediated silencing of the S100A10 gene attenuates plasmin generation and invasiveness of Colo 222 colorectal cancer cells. J. Biol. Chem. 279:2053-62
218. Konnikova L, Kotecki M, Kruger MM, Cochran BH. 2003. Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells. BMC Cancer 3:23
219. Ritter U, Damm-Welk C, Fuchs U, Bohle RM, Borkhardt A, Woessmann W. 2003. Design and evaluation of chemically synthesized siRNA targeting the NPM-ALK fusion site in anaplastic large cell lymphoma (ALCL). Oligonucleotides 13:365-73